Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDPAIN: Perioperative Esketamine in Endometriosis Surgery
NCT07881562Phase 4Not yet recruiting
- Sponsor
- Region Skåne
- Start
- Jan 2028
- Primary completion
- Dec 2030
01
Overview
Phase 4, randomised, triple-blind trial of esketamine in postoperative pain (2 arms), sponsored by Region Skåne. Primary endpoint: Time weighted longitudinal postoperative pain measurement at 48 hours. Planned start Jan 2028; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07881562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07881562.